By Lauran Neergaard

The U.S. could soon be giving at least a million COVID-19 vaccinations a day despite the sluggish start, Dr. Anthony Fauci said Tuesday, even as he warned of a dangerous next few weeks as the coronavirus surges.

The slow pace is frustrating health officials and a desperate public alike, with only about a third of the first supplies shipped to states used as of Tuesday morning, just over three weeks into the vaccination campaign.

“Any time you start a big program, there’s always glitches. I think the glitches have been worked out,” the nation's top infectious disease expert told The Associated Press.

Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Now, with the holidays over, “once you get rolling and get some momentum, I think we can achieve 1 million a day or even more,” Fauci said. He called President-elect Joe Biden’s goal of 100 million vaccinations in his first 100 days “a very realistic, important, achievable goal.”

It’s an optimistic prediction considering the logistical hurdles facing states and counties as they struggle to administer rationed vaccine supplies amid rising COVID-19 hospitalizations. Fauci pointed to California’s swamped hospitals and exhausted workers even before holiday travel and family gatherings added fuel to the outbreak.

Fauci estimated that between 70% and 85% of the U.S. population will need to be vaccinated to achieve “herd immunity,” meaning enough people are protected that it’s difficult for the virus to continue spreading. That translates to as many as 280 million people.

He said he is hoping to achieve that by the start of next fall.

The coronavirus has killed more than 356,000 Americans, and the next few weeks could bring another jump in infections nationally that “could make matters even worse,” Fauci said.

The Trump administration had promised to provide states enough vaccine for 20 million people in December and fell short even as states struggled with their role — getting shots into people’s arms, starting mostly with health care workers and nursing home residents.

According to the Centers for Disease Control and Prevention, roughly 4.8 million doses of more than 17 million delivered had been used by Tuesday morning. That is probably an undercount because of delays in reporting, but it is far fewer than experts had hoped.

Still, Fauci pointed to a celebrated moment in history to back up his projection of ramped-up inoculations: In 1947, New York City vaccinated more than 6 million people against a smallpox outbreak in less than a month — and “one of them was me as a 6-year-old boy."

If a single city could do such mass vaccinations in weeks, “this is not something that is far-fetched” for an entire country, he said. “You can use school auditoriums, you can use stadiums. You can really ramp up the contribution of pharmacies.”

At that stepped-up pace, the country could see an impact on infections as early as spring — and hopefully by early fall, “you could start thinking about returning to some degree of normality,” Fauci said.

Amid mounting frustration over the slow vaccine rollout, governors and other politicians are talking tough and in some cases proposing to bend the rules to get people vaccinated more quickly. Health care workers and nursing home patients are still getting priority in most places.

New York Gov. Andrew Cuomo threatened to fine hospitals that don’t use their vaccine allotments fast enough, saying: “Move it quickly. We’re serious.”

Gov. Henry McMaster of South Carolina said hospitals and health workers have until Jan. 15 to get a shot or they will have to “move to the back of the line.” As of Monday, the state had given out less than half its initial allotment of the Pfizer vaccine to about 43,000 people.

In North Carolina, Gov. Roy Cooper called in the National Guard to help speed things up.

In California, where just 1% of the population has been vaccinated, Gov. Gavin Newsom said he wants to give providers the flexibility to dispense shots to people not on the priority list if doses are in danger of going to waste.

New York’s mayor suggested vaccine eligibility be widened to get things moving.

There’s no sign yet that a more contagious variant of the coronavirus first found in Britain — which forced England into another national lockdown on Tuesday — will outwit the vaccines. Fauci’s colleagues at the National Institutes of Health are doing their own testing to be sure, just as vaccine manufacturers are.

While the variant has been found in several states “it is certainly not dominant,” Fauci said. “We don’t know where it’s going. We’re going to follow it very carefully.”

The more contagious virus makes it even more important that people follow the public health precautions Fauci has preached for months, including wearing a mask, keeping your distance, and avoiding crowds.

In addition, scientists are warily watching a different variant found in South Africa but not yet reported in the U.S. There have been reports that the mutation might make treatments called monoclonal antibodies less likely to work. Fauci said he couldn’t confirm that, but U.S. scientists will investigate.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
3D Printed, D2C Prosthetics; Future of Human-Robot Collaboration
On this episode of Cheddar Innovates: Founder of Unlimited Tomorrow breaks down how he is creating completely 3D printed prosthetics to make them more affordable, customizable, and accessible; Chief Technology Officer of Zebra Technologies explains what the future of collaboration between robots and humans may look like; A look at Curiosity Stream's 'Mystery of the Roman Skulls.'
The Promise of 'Treg' Cells In ALS Treatments
Each year about 5,000 people are diagnosed with ALS. This is such an important conversation. A disease that can weaken a patient's muscles and impact physical function. However, one research company says that could all change soon. Coya Therapeutics has developed a way to isolate a patient problematic T-cells in order to help ultimately slow the decline of not just ALS, but potentially Alzheimer's and other neurodegenerative diseases as well. Founder and Chief Executive Officer at Coya Therapeutics, Dr. Howard Berman, joined Cheddar to discuss more.
Hydrogen Expected to Play Important Part in Achieving Net-Zero Future
In the fight against climate change, much of the conversation revolves around reducing greenhouse gases like carbon dioxide or methane - and attempting to raise oxygen levels. But there's another gas - hydrogen - that could play a big role in the fight for the climate. Marco Alvera, CEO of Italian energy infrastructure company Snam and author of the book, 'The Hydrogen Revolution,' joined Cheddar Climate to explain the role hydrogen plays in helping achieve a net-zero future.
Walmart, Kroger Raise At-Home COVID-19 Test Prices
Americans looking to purchase at-home COVID-19 tests will now have to shell out a bit more money after an agreement expired between the White House and companies to sell the tests at cost. The price of Abbot's BinaxNow test kit from October to December was $14 apiece; on Tuesday, Walmart's website listed the test for $19.88, and Kroger listed the tests for $23.99. Carbon Health Regional Clinical Director Dr. Bayo Curry-Winchell joined Cheddar News' Closing Bell to discuss the impact higher prices will have as the nation experiences another surge in cases.
Kids Head Back To School As Omicron Surges In NYC
As millions of kids go back to school, districts across the country are determined to keep class in person, despite a surge in COVID cases. In New York City, Mayor Eric Adams has vowed to keep the nation's largest school system open amid Omicron, citing the disastrous effect of remote learning on students. Oswald Feliz, NYC council member who sits on the health and education committee, joined Cheddar to discuss the city's plan to combat the recent surge and keep kids in school.
How Schools Are Preparing For Omicron
Schools across the country are determined to keep class in session, despite the rapidly-spreading Omicron variant. While many parents prefer in-person learning, they also worry whether the current public health guidelines will be enough to protect their kids. Erin Richards, national education reporter for USA Today, joined Cheddar to discuss how are schools are preparing for the surge to avoid another round of remote learning.
HP on New Products at CES 2022, Challenge of Reaching Carbon Net Zero by 2040
With the annual CES convention underway amid COVID, HP unveiled rolled out a number of new products virtually this year, including new gaming PCs and 4K display monitors. But as industries look toward a greener future, HP is working with the climate crisis in mind. James McCall, chief sustainability officer at HP, joined Cheddar's Kristen Scholer to discuss the company's climate goals, which includes reducing its carbon footprint to net-zero by 2040. He admitted that reaching the ambitious goal will be difficult because much of the company's emissions totals come from third parties. "A large part of our footprint is outside of HP's direct control. A lot of it comes either from our incoming supply chain, the materials, our manufacturing process, or about 30 to 40 percent of it comes from our consumer-use base," McCall told Cheddar.
Pfizer, BioNTech to Develop mRNA Shingles Vaccine
Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
Researchers Travel to "Doomsday" Thwaites Glacier to Test Ocean Temperature
The potential collapse of the Thwaites glacier in Antarctica has been deemed a potential "doomsday event" — researchers and scientists say its melting and collapse could raise global sea levels by at least two feet, enough to destroy coastal communities around the world. One team of scientists is traveling to the Thwaites glacier to drill below in order to gauge current ocean temperatures and attempt to model possible outcomes. David Holland, professor at NYU and Principal Investigator for the International Thwaites Glacier Collaboration, joins Cheddar Climate to discuss the glacier's potential collapse, his team's research plan, and more.
Schools Prepare to Reopen Despite Rising Covid Cases
As winter break wraps up and COVID-19 cases hit record levels, the majority of school districts are returning to in-person classes. While some public schools in large cities have shifted to remote learning for the beginning of the year, the schools that are reopening campuses are determined to avoid the academic, social, and logistical challenges that come with a virtual classroom. Cheddar News is joined by Keith Powers, NYC Council Member, to discuss.
Load More